Literature DB >> 22102086

Fibrillary glomerulonephritis in a patient with systemic lupus erythematosus: a rare association.

Zeenat Y Bhat1, Xu Zeng, Jaideep Hingorani, Salman Khan, Madhumita Jena Mohanty.   

Abstract

We report the case of a 28-year-old man with systemic lupus erythematosus (SLE) and rapidly progressive glomerulonephritis (RPGN) due to fibrillary glomerulonephritis (FGN). The patient had a history of SLE and had been treated with mycophenolate mofetil, prednisone, and intravenous cyclophosphamide for his renal and extra-renal manifestations. In spite of this treatment, he developed RPGN. A subsequent renal biopsy revealed diffuse proliferative glomerulonephritis with fibrillary deposits. SLE is rarely associated with FGN, however FGN should be considered in the differential diagnosis of any SLE patient with RPGN.

Entities:  

Mesh:

Year:  2011        PMID: 22102086     DOI: 10.1007/s11255-011-0073-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  9 in total

1.  Fingerprint and other organised deposits in lupus nephritis.

Authors:  A Hvala; T Kobenter; D Ferluga
Journal:  Wien Klin Wochenschr       Date:  2000-08-25       Impact factor: 1.704

2.  Immuotactoid glomerulopathy (fibrillary glomerulonephritis).

Authors:  Stephen M Korbet; Melvin M Schwartz; Edmund J Lewis
Journal:  Clin J Am Soc Nephrol       Date:  2006-09-13       Impact factor: 8.237

Review 3.  Clinical features, predictors of disease progression and results of renal transplantation in fibrillary/immunotactoid glomerulopathy.

Authors:  P H Pronovost; H R Brady; M E Gunning; O Espinoza; H G Rennke
Journal:  Nephrol Dial Transplant       Date:  1996-05       Impact factor: 5.992

4.  Clinical and pathologic features of fibrillary glomerulonephritis.

Authors:  S S Iskandar; R J Falk; J C Jennette
Journal:  Kidney Int       Date:  1992-12       Impact factor: 10.612

5.  Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy.

Authors:  A Fogo; N Qureshi; R G Horn
Journal:  Am J Kidney Dis       Date:  1993-09       Impact factor: 8.860

6.  Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the congo red-negative amyloid-like fibrils of fibrillary glomerulopathy.

Authors:  G C Yang; R Nieto; I Stachura; G R Gallo
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

7.  Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.

Authors:  Jordan L Rosenstock; Glen S Markowitz; Anthony M Valeri; Giuseppe Sacchi; Gerald B Appel; Vivette D D'Agati
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

8.  Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia.

Authors:  Eswari Vilayur; Paul Trevillian; Mark Walsh
Journal:  Nat Clin Pract Nephrol       Date:  2008-11-25

9.  Fibrillary glomerulonephritis and renal failure in a child with systemic lupus erythematosus.

Authors:  Shina Menon; Xu Zeng; Rudolph Valentini
Journal:  Pediatr Nephrol       Date:  2009-03-24       Impact factor: 3.714

  9 in total
  3 in total

1.  Fibrillary glomerulonephritis complicated by membranous nephropathy in a patient with tuberculosis.

Authors:  Xueguang Liu; Hong Liu; Zhonghua Zhao; Zhigang Zhang; Xiaoqiang Ding
Journal:  Int Urol Nephrol       Date:  2012-07-24       Impact factor: 2.370

Review 2.  Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9).

Authors:  Nattawat Klomjit; Mariam Priya Alexander; Ladan Zand
Journal:  Kidney360       Date:  2020-07-08

3.  Establishing a tree shrew model of systemic lupus erythematosus and cell transplantation treatment.

Authors:  Guang-Ping Ruan; Xiang Yao; Ju-Fen Liu; Jie He; Zi-An Li; Jian-Yong Yang; Rong-Qing Pang; Xing-Hua Pan
Journal:  Stem Cell Res Ther       Date:  2016-08-24       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.